Login / Signup

Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy.

Hiroko MinatogawaNaoki IzawaTakashi KawaguchiTempei MiyajiKazuhiro ShimomuraHonda KazunoriHirotoshi IiharaYasushi OhnoYusuke InadaHitoshi AriokaHajime MoritaNaoya HidaMitsuhiro SugawaraChikatoshi KatadaShuichi NawataHiroo IshidaAyako TsuboyaTakashi TsudaTakuhiro YamaguchiTakako Eguchi Nakajima
Published in: BMJ open (2020)
UMIN000032269.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • double blind
  • placebo controlled
  • phase ii
  • chemotherapy induced
  • study protocol
  • low dose
  • high dose
  • neuropathic pain
  • randomized controlled trial
  • squamous cell carcinoma
  • spinal cord